Investor's Business Daily on MSN
CorMedix clears key benchmark, hitting 80-plus RS rating
CorMedix earns the No. 53 rank among its peers in the Medical-Biomed/Biotech industry group. Genmab ADR GMAB, Krystal Biotech ...
Investor's Business Daily on MSN
Kura Oncology shows market leadership with jump to 93 RS rating
On Tuesday, Kura Oncology KURA cleared a key technical benchmark, with its Relative Strength (RS) Rating rising into the 90-plus percentile with an upgrade to 93, up from 87 the day before. Please ...
This year, Demand Gen Report has released a collection of in-depth analyses that map out the future of the industry.
Clearwater’s boss, Sandeep Sahai, believes stepping away from the public markets will allow the company to make big, bold ...
The NBR chief said that connecting the tax database with the CDBL will significantly simplify the collection of dividend information from the large number of investors in the stock market who receive ...
Motley Fool co-founder and CEO Tom Gardner closes out 2025 with a big-picture look at what's driven the market's strong run, why enthusiasm can push valuations too high, and how investors can stay ...
There are many ways to measure a child care program's quality. Michigan's Great Start to Quality system is designed to ...
Discover the Center for Research in Security Prices (CRSP) at the Booth School of Business, including its historical data on ...
“What I see is spreadsheets aren’t going away. BI tools aren’t going away. There’s over a billion active users of Excel,” ...
Fueled by ambition, startups like OpenAI are adopting 996 work schedules—grinding 9 a.m. to 9 p.m., six days a week. The ...
Oracle spooks the stock market after key partner refuses to fund $10B Michigan data center project - SiliconANGLE ...
Oracle (ORCL) is rated 'Buy' due to a major valuation dislocation versus its $523B RPO backlog, despite recent CapEx-driven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results